Azithromycin Dosage: Why a Five Day Course Keeps Working After You Stop

Azithromycin is the antibiotic people finish on a Friday and keep benefiting from into the following week. That is not marketing. Its serum half life is around 68 to 72 hours, roughly forty times longer than amoxicillin, and tissue concentrations outlast serum concentrations by a wide margin. It is also the reason a three day course and a five day course deliver almost identical total drug exposure. This guide covers the labelled doses by infection, the pharmacokinetics that explain them, and the cardiac warning that decides who should not take it.

Adult dosing by infection

Azithromycin dosing is indication specific rather than one standard regimen. The labelled adult doses are as follows.

Infection	Regimen
Community acquired pneumonia (mild), pharyngitis or tonsillitis as second line, uncomplicated skin and skin structure infection	500 mg on day 1, then 250 mg once daily on days 2 to 5
Acute bacterial exacerbation of chronic bronchitis or COPD	500 mg once daily for 3 days, or 500 mg on day 1 then 250 mg daily on days 2 to 5
Acute bacterial sinusitis	500 mg once daily for 3 days
Non gonococcal urethritis and cervicitis, genital ulcer disease (chancroid)	One single 1 gram dose
Gonococcal urethritis and cervicitis	One single 2 gram dose

The familiar five day pack totals 1.5 grams. So does the three day regimen. Tablets can be taken with or without food. Available strengths here include Azee 250mg, Azithromycin 500mg and Azee 1000mg.

Three days or five days, and why both work

A two way crossover study gave 12 healthy adults the same 1500 mg total, either as a five day regimen or a three day regimen, and measured the difference.

Parameter	3 day regimen	5 day regimen
Peak serum concentration, day 1	0.44 mcg/mL	0.43 mcg/mL
Peak serum concentration, day 3	0.54 mcg/mL	0.24 mcg/mL
Total serum exposure across the course	17.4 mcg·hr/mL	14.9 mcg·hr/mL
Serum half life	71.8 hours	68.9 hours

Total exposure across the whole course is comparable between the two. The three day course front loads it into higher daily peaks; the five day course spreads it out. Neither is a stronger course. The choice is driven by the infection and by which schedule a person is more likely to complete.

The half life figure is the important one. At roughly 70 hours, it takes around two weeks for the drug to be effectively cleared after the last tablet. A five day course therefore covers a considerably longer treatment window than five days, which is precisely why the pack is short.

Absorption and the food question

Absolute bioavailability of the 250 mg capsule is 38 percent, so most of a dose never reaches the bloodstream. Peak serum concentration after a single 500 mg dose in fasted volunteers is about 0.5 mcg/mL, reached at roughly 2.2 hours.

Food effects differ by formulation. In healthy subjects given 500 mg as tablets with a high fat meal, peak concentration rose 23 percent while total exposure was unchanged. With the oral suspension given to 28 adults with food, peak concentration rose 56 percent and total exposure was unchanged. Since total exposure drives the antibacterial effect and it does not move with food, tablets can reasonably be taken either way. Two 250 mg tablets are bioequivalent to a single 500 mg tablet.

Paediatric dosing

Children are dosed by weight and by indication, from 6 months of age for most conditions.

Infection	Regimen
Acute otitis media (6 months and older)	30 mg/kg once, or 10 mg/kg daily for 3 days, or 10 mg/kg on day 1 then 5 mg/kg on days 2 to 5
Acute bacterial sinusitis (6 months and older)	10 mg/kg once daily for 3 days
Community acquired pneumonia (6 months and older)	10 mg/kg on day 1, then 5 mg/kg once daily on days 2 to 5
Pharyngitis or tonsillitis (2 years and older)	12 mg/kg once daily for 5 days

Otitis media is the one indication with three labelled alternatives, including a single 30 mg/kg dose. Dispersible paediatric forms stocked here include Azee 100 DT and Azeetop 100 DT.

The cardiac warning that decides eligibility

Azithromycin prolongs the QT interval, and cases of torsades de pointes have been reported. The label states this risk can be fatal and should be weighed in anyone with known QT prolongation, a history of torsades de pointes, other proarrhythmic conditions, or who takes other QT prolonging drugs.

Separately, the label reports that some observational studies have shown an approximately two fold increased short term risk of acute cardiovascular death in adults given azithromycin compared with other antibacterials, including amoxicillin. That comparison is worth reading carefully. It is a relative increase over a very small baseline, drawn from observational data rather than randomised trials, and it applies to short term risk during treatment. It is not a reason to refuse a needed antibiotic, but it is a real reason to prefer an alternative when one is equally suitable and the person has cardiac risk factors.

Practical implications: significant existing QT prolongation, low potassium or magnesium, and concurrent use of other QT prolonging medicines all shift the balance away from azithromycin. This needs a prescriber with your medication list, not a self assessment.

Other serious warnings

Severe hepatotoxicity has been reported, including hepatitis, cholestatic jaundice, hepatic necrosis and hepatic failure, some resulting in death. Azithromycin should be discontinued immediately if signs of hepatitis appear.

Serious allergic and skin reactions include angioedema, anaphylaxis, acute generalised exanthematous pustulosis, Stevens Johnson syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms. The label makes an unusual observation here: after apparently successful treatment of the allergic symptoms, symptoms recurred in some patients once symptomatic therapy stopped, without further azithromycin exposure, requiring prolonged observation. The long tissue half life is a suspected but unconfirmed explanation.

Infantile hypertrophic pyloric stenosis has been reported after use in neonates treated up to 42 days of life, so vomiting or irritability with feeding in that group needs prompt medical review. Azithromycin may also worsen muscle weakness in myasthenia gravis, and Clostridioides difficile associated diarrhoea can follow treatment.

Common side effects in context

Most reported effects in trials were mild to moderate and reversible on stopping.

Adverse reaction	Reported range
Nausea	3 to 18 percent
Diarrhoea	5 to 14 percent
Abdominal pain	3 to 7 percent
Vomiting	2 to 7 percent

The ranges are wide because they pool different indications and doses. The single gram and two gram doses used for sexually transmitted infections produce noticeably more nausea than a 250 mg daily tablet, which is the main reason those single doses are sometimes poorly tolerated.

Discontinuation rates were low. About 0.7 percent of patients in the five day multiple dose trials stopped because of treatment related reactions, and 0.6 percent of adults given 500 mg daily for three days.

Azithromycin resistance is a real constraint

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes is high in many regions, which is why the label lists pharyngitis and tonsillitis as a second line indication rather than first line. Penicillin remains the drug of choice for streptococcal sore throat where there is no allergy.

Azithromycin's very long half life contributes to this. Sub therapeutic concentrations persist for weeks after a course, which is an ideal environment for selecting resistant organisms. That is an argument for using it where it is genuinely indicated rather than as a general purpose antibiotic, and for not repeating courses casually.

What azithromycin does not treat

It has no effect on viruses. Colds, most sore throats, most acute bronchitis and influenza do not respond to it. Acute bronchitis in otherwise healthy adults is overwhelmingly viral, and azithromycin is one of the most commonly misprescribed antibiotics for it.

Where treatment for a sexually transmitted infection is involved, testing and partner notification matter as much as the tablet, and current first line recommendations for gonorrhoea in particular have moved away from azithromycin monotherapy in many countries because of resistance. Anyone treating a suspected sexually transmitted infection should be doing so on the basis of testing and current local guidance.

How it compares with the other macrolides

Azithromycin, clarithromycin and erythromycin share a mechanism but behave very differently in practice, and the differences drive the choice more than potency does.

	Azithromycin	Clarithromycin	Erythromycin
Typical dosing	Once daily, 3 to 5 days	Twice daily, 7 to 14 days	Two to four times daily
Serum half life	About 68 to 72 hours	About 3 to 7 hours	About 1.5 to 2 hours
CYP3A4 interaction potential	Low	High	High
Gastrointestinal tolerance	Better	Intermediate	Poorest

Erythromycin is a strong motilin receptor agonist, which is why it causes so much cramping and nausea, and also why it is sometimes used deliberately as a gut prokinetic. Clarithromycin is the most potent CYP3A4 inhibitor of the three, so it interacts with statins, certain calcium channel blockers, some anticoagulants and many other drugs to a degree azithromycin generally does not. All three prolong the QT interval. Products here include Zoclar 500mg clarithromycin and Althrocin 500mg erythromycin.

Missed doses and finishing a short course

Because azithromycin is dosed once daily and the courses are short, a missed dose is proportionally a larger fraction of the total than with a four times daily antibiotic. Take a missed dose as soon as you remember unless the next one is nearly due, and do not double up.

The long half life provides genuine forgiveness here. Missing one day of a five day course does not collapse the treatment, because drug from earlier doses is still present at meaningful concentrations. That is a reason not to panic, not a reason to be casual, and completing the course your prescriber set remains the right approach.

Interactions worth checking

The most consequential interactions are with other QT prolonging drugs, which includes certain antiarrhythmics, some antipsychotics, some antidepressants and other macrolides and fluoroquinolones. Combining them compounds the arrhythmia risk described above.

Antacids containing aluminium or magnesium reduce peak azithromycin concentrations when taken at the same time, so separating them by a couple of hours is sensible. Azithromycin has a considerably lower potential for cytochrome P450 interactions than erythromycin or clarithromycin, which is one of its practical advantages, but that does not make it interaction free.

Safety information

Azithromycin is a prescription only medicine in the United States, United Kingdom, Australia and Canada. It should be used only where a bacterial infection is proven or strongly suspected. Do not take it alongside other QT prolonging medicines without medical advice, and tell your prescriber about any heart rhythm problem, liver disease, myasthenia gravis or previous reaction to a macrolide. Stop and seek medical help if you develop yellowing of the skin or eyes, a spreading rash with blistering, or palpitations and fainting. Speak to a licensed clinician before starting or changing this medicine. For the beta lactam alternative, see our amoxicillin and clavulanate dosage guide.

References

• FDA prescribing information, azithromycin tablets: sections 2.1 and 2.2 dosage and administration, 5.1 to 5.7 warnings and precautions, 6.1 clinical trials experience, and 12.3 pharmacokinetics
• DailyMed label, azithromycin: indications, contraindications and adverse reactions sections
• Two way crossover pharmacokinetic study in 12 healthy adults comparing 1500 mg given over 3 days and over 5 days, reported in section 12.3 of the label